Coming up next:
4 - 7 May 2021
This symposium will provide a forum for this emerging field of cell type and tissue origination in the single-cell genomics era. We will discuss fundamental questions such as the origins of cell types in the evolution of multicellularity, their diversification in divergent animal lineages and the molecular evolution of regulatory networks underlying the specification of cell types and tissues.
7 - 9 July 2021
This symposium will cover a broad range of topics in prokaryotic biology, including antibiotic-related research, network biology, bacterial communities, cell biology, regulation & signalling, pathogenesis and evolution. Emphasis will be placed on novel approaches that drive each field or have the potential to revolutionise future research in microbiology.
15 - 17 September 2021
This symposium will provide a platform for bringing together leading researchers from computational biology, various “omics” fields and technology development to present their latest work and discuss applications, future ideas and the challenges for integrating large-scale biological data across different biological technologies and disciplines.
5 - 9 October 2021
"Seeing is Believing" presents the most exciting new imaging technologies and shows how they can answer important biological questions.
13 - 16 October 2021
This symposium will explore the diverse, dynamic and multifaceted roles of RNA across a spectrum of cellular processes. It will provide an interdisciplinary discussion of the roles of non-coding RNAs in both prokaryotes and eukaryotes, with the aim of enhancing our understanding of gene regulation and function.
17 - 20 November 2021
Metabolism and epigenetics are intricately linked, playing key roles in development, cancer, immune signalling and aging. This symposium brings together world-leading researchers exploring this nexus and will focus in particular on how metabolites and metabolic networks impact gene regulation, on recently discovered roles of metabolites in disease and how this open novel therapeutic avenues.